Accuray, Inc. (NASDAQ:ARAY)
CAPS Rating:
The Company has developed the commercially available intelligent robotic radiosurgery system, the CyberKnife system, designed to treat solid tumors anywhere in the body as an alternative to traditional surgery.
RSS Headlines
Fool UK
Recs
Buying at a discount and there is really nothing to show why they are so undervalued except for S&P downgrade scare. Waiting for some consolidation